HS
HighVista Strategies’s Cogent Biosciences COGT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.03M | Buy |
283,186
+3,513
| +1% | +$25.2K | 0.75% | 42 |
|
2025
Q1 | $1.68M | Hold |
279,673
| – | – | 0.65% | 53 |
|
2024
Q4 | $2.18M | Buy |
279,673
+54,040
| +24% | +$422K | 0.81% | 40 |
|
2024
Q3 | $2.44M | Sell |
225,633
-55,460
| -20% | -$599K | 0.84% | 35 |
|
2024
Q2 | $2.37M | Hold |
281,093
| – | – | 0.87% | 34 |
|
2024
Q1 | $1.89M | Hold |
281,093
| – | – | 0.67% | 51 |
|
2023
Q4 | $1.65M | Buy |
281,093
+82,506
| +42% | +$485K | 0.6% | 58 |
|
2023
Q3 | $1.94M | Sell |
198,587
-17,543
| -8% | -$171K | 0.9% | 36 |
|
2023
Q2 | $2.56M | Buy |
216,130
+32,146
| +17% | +$381K | 1.17% | 27 |
|
2023
Q1 | $1.99M | Hold |
183,984
| – | – | 1.62% | 22 |
|
2022
Q4 | $2.13M | Buy |
183,984
+65,049
| +55% | +$752K | 1.26% | 23 |
|
2022
Q3 | $1.78M | Buy |
+118,935
| New | +$1.78M | 1.01% | 32 |
|